Pictured: Craig Thompson
Perspective
By Craig Thompson, MD, President and CEO  |  Friday, December 23, 2011

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

Pictured: Blood donation
In the News
By Media Staff  |  Thursday, December 22, 2011

After signing up for the National Bone Marrow Registry “Be The Match,” a Montclair man was recently called to donate peripheral blood stem cells for a sick child. He was inspired to join the registry after an anonymous donor saved the life of his own son, who had received a bone marrow transplant.

Philanthropy
By Memorial Sloan Kettering  |  Wednesday, December 21, 2011

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

Pictured: Hans-Guido Wendel
Profile
By Jim Stallard, MA, Writer/Editor  |  Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Pictured: Nancy Lee
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, December 19, 2011

People with cancer of the nasopharynx, an area behind the nose, may benefit from a new combination therapy, according to an international study led by Memorial Sloan Kettering radiation oncologist Nancy Y. Lee.

Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, December 15, 2011

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Honor
By Media Staff  |  Wednesday, December 14, 2011

Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

Pictured: Structural formula of IBNtxA
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 12, 2011

A Memorial Sloan Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Pictured: Clifford Hudis
Honor
By Memorial Sloan Kettering  |  Wednesday, December 7, 2011

Memorial Sloan Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.

Pictured: Mark Kris & Ann Culkin
Honor
By Memorial Sloan Kettering  |  Monday, December 5, 2011

Congratulations to Mark Kris, Chief of the Thoracic Oncology Service, and Ann Culkin, nurse on the Thoracic Oncology Service, for receiving the Wholeness of Life Award 2011 from the HealthCare Chaplaincy.

Pictured: Lloyd J. Old
In Memoriam
By Memorial Sloan Kettering  |  Sunday, December 4, 2011

Memorial Sloan Kettering notes with sadness the death of Lloyd J. Old, who was internationally recognized as one of the founders and standard bearers of the field of tumor immunology.

Research
Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Social Media
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, November 29, 2011

This holiday season, we encourage Facebook fans to interact with us through our new Giving tab! You can make a donation, post a support or survivor badge on your wall for your friends to see, sign up to receive our supporter e-newsletter, learn about ways to get involved, and read stories featuring community fundraising events.

Facebook; Giving
Pictured: David Solit
In the Lab
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Center News

Stay Informed

Get the latest information about cancer care and research every month.